1. Home
  2. MIST vs BRFH Comparison

MIST vs BRFH Comparison

Compare MIST & BRFH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MIST
  • BRFH
  • Stock Information
  • Founded
  • MIST 2003
  • BRFH 2005
  • Country
  • MIST Canada
  • BRFH United States
  • Employees
  • MIST N/A
  • BRFH N/A
  • Industry
  • MIST Biotechnology: Pharmaceutical Preparations
  • BRFH Packaged Foods
  • Sector
  • MIST Health Care
  • BRFH Consumer Staples
  • Exchange
  • MIST Nasdaq
  • BRFH Nasdaq
  • Market Cap
  • MIST 53.9M
  • BRFH 43.8M
  • IPO Year
  • MIST N/A
  • BRFH N/A
  • Fundamental
  • Price
  • MIST $1.11
  • BRFH $2.52
  • Analyst Decision
  • MIST Strong Buy
  • BRFH Strong Buy
  • Analyst Count
  • MIST 2
  • BRFH 1
  • Target Price
  • MIST $9.50
  • BRFH $4.50
  • AVG Volume (30 Days)
  • MIST 1.6M
  • BRFH 7.3K
  • Earning Date
  • MIST 05-20-2025
  • BRFH 05-01-2025
  • Dividend Yield
  • MIST N/A
  • BRFH N/A
  • EPS Growth
  • MIST N/A
  • BRFH N/A
  • EPS
  • MIST N/A
  • BRFH N/A
  • Revenue
  • MIST N/A
  • BRFH $10,818,000.00
  • Revenue This Year
  • MIST N/A
  • BRFH $41.20
  • Revenue Next Year
  • MIST N/A
  • BRFH $42.03
  • P/E Ratio
  • MIST N/A
  • BRFH N/A
  • Revenue Growth
  • MIST N/A
  • BRFH 22.03
  • 52 Week Low
  • MIST $0.63
  • BRFH $1.44
  • 52 Week High
  • MIST $2.75
  • BRFH $4.61
  • Technical
  • Relative Strength Index (RSI)
  • MIST 43.96
  • BRFH 44.35
  • Support Level
  • MIST $1.28
  • BRFH $2.30
  • Resistance Level
  • MIST $1.32
  • BRFH $2.69
  • Average True Range (ATR)
  • MIST 0.12
  • BRFH 0.17
  • MACD
  • MIST 0.02
  • BRFH 0.02
  • Stochastic Oscillator
  • MIST 27.39
  • BRFH 29.24

About MIST Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).

About BRFH Barfresh Food Group Inc.

Barfresh Food Group Inc develops, manufactures and distributes ready to blend frozen beverages, including smoothies, shakes and frappes for restaurant chains and the foodservice industry. The company's proprietary, patented system uses portion-controlled pre-packaged beverage ingredients that deliver freshly made frozen beverages that are quick, cost efficient, and without waste. Barfresh provides both a single serve solution and a bulk format solution, ideal for high-volume locations. It has seven flavors available as part of its standard line vanilla shake, caribbean smoothie, triple berry smoothie, caramel macchiato frappe, strawberry banana smoothie, mocha frappe and mango burst smoothie and has the development capabilities to deliver custom flavors.

Share on Social Networks: